To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Oh absolutely no way.. oh gawd nightmare fuel @4:22 … ewwwww ughugh
I don’t eat weird shit. Not even commonly eaten weird shit… like oysters…and calamari…and any other delicacy people entertain
The world is a weird place,also love your vids!!!
I’m very underrated on YouTube and I have 300 subs! I need help promoting my channel and everyone is saying that I should have 500,000-1M Subs 🙏
Read this, T10A staff and subscribers.
(A stock to add to your watchlist is detailed below: it’s SLS, Sellas Life Sciences)
This information is for experienced investors, SLS (Sellas Life Sciences) is stupidly undervalued:
1. Sellas had 11m cash and cash equivalents reported in their 10Q, ended September 30th 2018; not enough to fund their research but we’ll get to that.
(http1s://seekingalpha.com/filing/4238845)
2. Sellas has good press releases going back to October which should have rose the stock price above $4 (with *momentum*); their drug NeuVax is a potential solution to breast cancer.
()
3. SLS was kept low by the current bleak market and 11.5m warrants issued in July for the option to buy in at $2.10 regardless of market value, which shorts used to criminally manipulated the stock price.
()
4. On October 17th and November 9th much of the combined volume of the two dates far exceeded $2.10 but aforementioned forces delayed the stock’s rise as (many fled in fear, confused and unaware of the short seller market manipulation).
()
5. Sellas is in discussions with potential partners, disclosed in a recent news release (You can use Ctrl+F and type the word “partner” into the findbar after following the link to Nov 15th’s announcement).
().
There are scarce warrants left to manipulate the stock price below $4 (short sellers are panicking), no more manipulating the stock. All we need is *momentum*.
Add SLS to your watchlists/StockTwits (an online investing social media platform), all investors should research and keep an eye on this stock (and see if I’m wrong).
No.2 insert Bruno Mars grenade song here
I might need ro wrap in a mosquito net, just to sleep tonight😶
Holy hell
This is some crazy stuff here thank you top Ten 😀😀😀👍 👍
Nice click bait…